Literature DB >> 10721914

The role of probiotic cultures in the control of gastrointestinal health.

R D Rolfe1.   

Abstract

The use of probiotics to enhance intestinal health has been proposed for many years. Probiotics are traditionally defined as viable microorganisms that have a beneficial effect in the prevention and treatment of specific pathologic conditions when they are ingested. There is a relatively large volume of literature that supports the use of probiotics to prevent or treat intestinal disorders. However, the scientific basis of probiotic use has been firmly established only recently, and sound clinical studies have begun to be published. Currently, the best-studied probiotics are the lactic acid bacteria, particularly Lactobacillus sp. and Bifidobacterium sp. However, other organisms used as probiotics in humans include Escherichia coli, Streptococcus sp., Enterococcus sp., Bacteroides sp., Bacillus sp., Propionibacterium sp. and various fungi. Some probiotic preparations contain mixtures of more than one bacterial strain. Probiotics have been examined for their effectiveness in the prevention and treatment of a diverse spectrum of gastrointestinal disorders such as antibiotic-associated diarrhea (including Clostridium difficile-associated intestinal disease), infectious bacterial and viral diarrhea (including diarrhea caused by rotavirus, Shigella, Salmonella, enterotoxigenic E. coli, Vibrio cholerae and human immunodeficiency virus/acquired immunodeficiency disorder, enteral feeding diarrhea, Helicobacter pylori gastroenteritis, sucrase maltase deficiency, inflammatory bowel disease, irritable bowel syndrome, small bowel bacterial overgrowth and lactose intolerance. Probiotics have been found to inhibit intestinal bacterial enzymes involved in the synthesis of colonic carcinogens. There are many mechanisms by which probiotics enhance intestinal health, including stimulation of immunity, competition for limited nutrients, inhibition of epithelial and mucosal adherence, inhibition of epithelial invasion and production of antimicrobial substances. Probiotics represent an exciting prophylactic and therapeutic advance, although additional investigations must be undertaken before their role in intestinal health can be delineated clearly.

Entities:  

Mesh:

Year:  2000        PMID: 10721914     DOI: 10.1093/jn/130.2.396S

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  122 in total

1.  Small Bowel Bacterial Overgrowth: Presentation, Diagnosis, and Treatment.

Authors:  Virmeet V. Singh; Phillip P. Toskes
Journal:  Curr Treat Options Gastroenterol       Date:  2004-02

2.  In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice.

Authors:  Elizabeth A Griffiths; Linda C Duffy; Floyd L Schanbacher; Haiping Qiao; Diane Dryja; Allen Leavens; Jon Rossman; Gary Rich; Douglas Dirienzo; Pearay L Ogra
Journal:  Dig Dis Sci       Date:  2004-04       Impact factor: 3.199

3.  Effects of Dietary Bacillus licheniformis on Gut Physical Barrier, Immunity, and Reproductive Hormones of Laying Hens.

Authors:  Yang Wang; Wei Du; Kai Lei; Baikui Wang; Yuanyuan Wang; Yingshan Zhou; Weifen Li
Journal:  Probiotics Antimicrob Proteins       Date:  2017-09       Impact factor: 4.609

4.  Salvia miltiorrhiza water-soluble extract, but not its constituent salvianolic acid B, abrogates LPS-induced NF-kappaB signalling in intestinal epithelial cells.

Authors:  J S Kim; A S Narula; C Jobin
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

5.  Monitoring of antibiotic-induced alterations in the human intestinal microflora and detection of probiotic strains by use of terminal restriction fragment length polymorphism.

Authors:  Cecilia Jernberg; Asa Sullivan; Charlotta Edlund; Janet K Jansson
Journal:  Appl Environ Microbiol       Date:  2005-01       Impact factor: 4.792

6.  Effect of the probiotic Lactobacillus murinus LbP2 on clinical parameters of dogs with distemper-associated diarrhea.

Authors:  Luis Delucchi; Martín Fraga; Pablo Zunino
Journal:  Can J Vet Res       Date:  2017-04       Impact factor: 1.310

Review 7.  Probiotics and medical nutrition therapy.

Authors:  Amy C Brown; Ana Valiere
Journal:  Nutr Clin Care       Date:  2004 Apr-Jun

8.  Antiobesity effect of Pediococcus pentosaceus LP28 on overweight subjects: a randomized, double-blind, placebo-controlled clinical trial.

Authors:  F Higashikawa; M Noda; T Awaya; N Danshiitsoodol; Y Matoba; T Kumagai; M Sugiyama
Journal:  Eur J Clin Nutr       Date:  2016-03-09       Impact factor: 4.016

9.  In vitro anti-Helicobacter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics.

Authors:  I V Pinchuk; P Bressollier; B Verneuil; B Fenet; I B Sorokulova; F Mégraud; M C Urdaci
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

10.  The in vitro susceptibility of Campylobacter spp. to the antibacterial effect of manuka honey.

Authors:  S M Lin; P C Molan; R T Cursons
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-09-26       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.